Clinical Trial Update: Icotinib or Whole Brain Irradiation in EGFR-mutant Lung Cancer [Phase 3]

View source ↗

Summary

A Phase 3 randomized trial comparing icotinib with whole brain irradiation in patients with EGFR-mutant non-small cell lung cancer and brain metastases has comp…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Brain Metastases
• Non-small Cell Lung Cancer

Drugs mentioned

• icotinib (icotinib)

Snippet

Sponsor: Guangdong Association of Clinical Trials | Conditions: Brain Metastasis, Non Small Cell Lung Cancer | Phase 3 | Status: COMPLETED